Print Page     Close Window

Investor Relations Home

Corporate Profile

Senomyx discovers novel natural high intensity sweeteners and flavor ingredients that boost taste sensations such as sweet. Our flavor ingredients help food beverage companies create or reformulate better-for-you products, for example, allowing them to significantly reduce the use of traditional, higher-calorie sweeteners, while maintaining the same taste. We also develop savory flavors, bitter taste blockers and cooling agents. Our products are used by many of the world’s leading food and beverage companies.

SNMX Investor Presentation
Stock QuoteMore »
SNMX (Common)
ExchangeNASDAQ (US Dollar)
Price$1.49
Change (%)0.00 (0.00%)
Volume0
Data as of 11/01/18 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore »
DateTitle 
11/02/18FIRMENICH SUCCESSFULLY COMPLETES TENDER OFFER TO ACQUIRE SENOMYX
GENEVA and PRINCETON, N.J. and SAN DIEGO, Nov. 2, 2018 /PRNewswire/ -- Firmenich is pleased to announce the completion of its acquisition of Senomyx, Inc. ("Senomyx"), a global leader in taste innovation and expert in sweet, cooling and bitter solutions. Strengthening Firmenich's taste and nutrition capabilities, this acquisition adds to the Group's excellence in creating healthy and great tasting food, drink and oral care experiences for its customers. Sentry Merger Sub, Inc., a wholly owned subsidiary of Firmenich Incorporated ("Purchaser"), has successfully completed its tender offer to purchase all of the outstanding shares of common stock of Senomyx (NASDAQ: SNMX), at a price of $1.50... 
Printer Friendly Version
10/04/18FIRMENICH COMMENCES TENDER OFFER TO ACQUIRE SENOMYX
GENEVA, Switzerland, PRINCETON, N.J. and SAN DIEGO, Oct. 4, 2018 /PRNewswire/ -- Firmenich Incorporated ("Firmenich") announced today that its wholly-owned U.S. subsidiary, Sentry Merger Sub, Inc. ("Sentry Merger Sub"), commenced the previously announced tender offer to acquire all of the outstanding common stock of Senomyx, Inc. ("Senomyx") (NASDAQ: SNMX) for $1.50 per share, net to the seller in cash, without any interest thereon and less any applicable withholding taxes. The tender offer is scheduled to expire at 12:00 midnight, New York City time, on November 2, 2018 (one minute after 11:59 p.m., New York City time, on November 1, 2018), unless extended in accordance with the merger agre... 
Printer Friendly Version
09/17/18FIRMENICH TO ACQUIRE SENOMYX, PIONEER IN TASTE INNOVATION
GENEVA, Switzerland and PRINCETON, N.J. and SAN DIEGO, Sept. 17, 2018 /PRNewswire/ -- Firmenich and Senomyx, Inc. (NASDAQ: SNMX) today announced that they have entered into a definitive merger agreement under which Firmenich will acquire all of the outstanding common stock of Senomyx for $1.50 per share in cash. This represents a premium of approximately 43% over Senomyx's closing price on September 14, 2018 and a premium of approximately 39% based on the prior 30-trading day volume-weighted average price (VWAP). The proposed transaction has been unanimously approved by the Boards of Directors of both Firmenich and Senomyx. The companies expect to close the transaction in the fourth quarter ... 
Printer Friendly Version
08/02/18Senomyx Reports Second Quarter 2018 Financial Results
SAN DIEGO, Aug. 2, 2018 /PRNewswire/ -- Senomyx, Inc. (NASDAQ: SNMX), a leading company using proprietary taste science technologies to discover, develop, and commercialize novel flavor ingredients and natural high intensity sweeteners for the food, beverage, and ingredient supply industries, today reported financial results for the second quarter ended June 30, 2018. "Senomyx completed a strong first half of 2018, building on the successful results we achieved during the prior quarter," stated John Poyhonen, President and Chief Executive Officer of the Company. "We exceeded our financial guidance for the second quarter and are well positioned to meet key corporate and R&D goals in t... 
Printer Friendly Version
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources

© 2014- Senomyx, Inc., All Rights Reserved.